These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28572165)

  • 1. Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study.
    van Galen KPM; de Kleijn P; Foppen W; Eikenboom J; Meijer K; Schutgens REG; Fischer K; Cnossen MH; de Meris J; Fijnvandraat K; van der Bom JG; Laros-van Gorkom BAP; Leebeek FWG; Mauser-Bunschoten EP;
    Haematologica; 2017 Sep; 102(9):1486-1493. PubMed ID: 28572165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcome after Joint Bleeds in Von Willebrand Disease Compared to Haemophilia A: A Post Hoc Analysis.
    van Galen KPM; Timmer M; de Kleijn P; Leebeek FWG; Foppen W; Schutgens REG; Eikenboom J; Meijer K; Fijnvandraat K; Laros-van Gorkom BAP; Twisk JW; Mauser-Bunschoten EP; Fischer K;
    Thromb Haemost; 2018 Oct; 118(10):1690-1700. PubMed ID: 30273954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.
    van Galen KPM; Sanders YV; Vojinovic U; Eikenboom J; Cnossen MH; Schutgens REG; van der Bom JG; Fijnvandraat K; Laros-Van Gorkom BAP; Meijer K; Leebeek FWG; Mauser-Bunschoten EP;
    Haemophilia; 2015 May; 21(3):e185-e192. PubMed ID: 25854528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophilic arthropathy in patients with von Willebrand disease.
    van Galen KP; Mauser-Bunschoten EP; Leebeek FW
    Blood Rev; 2012 Nov; 26(6):261-6. PubMed ID: 23010260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint assessment in von Willebrand disease. Validation of the Haemophilia Joint Health score and Haemophilia Activities List.
    van Galen KPM; Timmer MA; de Kleijn P; Fischer K; Foppen W; Schutgens REG; Eikenboom J; Meijer K; Cnossen MH; Fijnvandraat K; van der Bom JG; Laros-van Gorkom BAP; Leebeek FWG; Mauser-Bunschoten EP; Win Study Group OBOT
    Thromb Haemost; 2017 Aug; 117(8):1465-1470. PubMed ID: 28492695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
    de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
    Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
    Berntorp E
    Semin Thromb Hemost; 2006 Sep; 32(6):621-5. PubMed ID: 16977572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint surgery in von Willebrand disease: a multicentre cross-sectional study.
    van Galen KPM; Meijer K; Vogely HC; Eikenboom J; Schutgens REG; Cnossen MH; Fijnvandraat K; van der Bom JG; Laros-van Gorkom BAP; Leebeek FWG; Mauser-Bunschoten EP;
    Haemophilia; 2016 Mar; 22(2):256-262. PubMed ID: 26551280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and von Willebrand's disease (vWD).
    Abshire TC
    Thromb Res; 2006; 118 Suppl 1():S3-7. PubMed ID: 16580053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sports participation and physical activity in patients with von Willebrand disease.
    Atiq F; Mauser-Bunschoten EP; Eikenboom J; van Galen KPM; Meijer K; de Meris J; Cnossen MH; Beckers EAM; Laros-van Gorkom BAP; Nieuwenhuizen L; van der Bom JG; Fijnvandraat K; Leebeek FWG;
    Haemophilia; 2019 Jan; 25(1):101-108. PubMed ID: 30427095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.
    Berntorp E; Windyga J;
    Haemophilia; 2009 Jan; 15(1):122-30. PubMed ID: 19149848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience of prophylactic treatment in von Willebrand disease.
    Lethagen S
    Thromb Res; 2006; 118 Suppl 1():S9-11. PubMed ID: 16616322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype.
    Kempers EK; van Kwawegen CB; de Meris J; Schols SEM; van Galen KPM; Meijer K; Cnossen MH; van der Bom JG; Fijnvandraat K; Eikenboom J; Atiq F; Leebeek FWG;
    Haemophilia; 2022 Mar; 28(2):278-285. PubMed ID: 34964530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 3 von Willebrand disease: assessment of complications and approaches to treatment -- results of a patient and Hemophilia Treatment Center Survey in the United States.
    Sumner M; Williams J
    Haemophilia; 2004 Jul; 10(4):360-6. PubMed ID: 15230950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prophylaxis in von Willebrand disease.
    Berntorp E; Petrini P
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S23-6. PubMed ID: 15849523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease.
    Lak M; Peyvandi F; Mannucci PM
    Br J Haematol; 2000 Dec; 111(4):1236-9. PubMed ID: 11167767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia.
    van den Berg HM; Fischer K; Mauser-Bunschoten EP; Beek FJ; Roosendaal G; van der Bom JG; Nieuwenhuis HK
    Br J Haematol; 2001 Mar; 112(3):561-5. PubMed ID: 11260054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network.
    Holm E; Carlsson KS; Lövdahl S; Lail AE; Abshire TC; Berntorp E
    Haemophilia; 2018 Jul; 24(4):628-633. PubMed ID: 29626372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthopaedic surgery in patients with von Willebrand disease.
    Siboni SM; Biguzzi E; Solimeno LP; Pasta G; Mistretta C; Mannucci PM; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):133-40. PubMed ID: 23992395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.